Skip to main content
. 2014 Jun 17;16(3):R126. doi: 10.1186/ar4583

Figure 4.

Figure 4

Therapeutic effects of anti-CXCL10 or control antibody treatment in C-protein-induced myositis (CIM). After inducing CIM, mice were treated with anti-CXCL10 antibody or control antibody (anti-RVG1) or were not treated (n = 17 per group). The group treated with anti-CXCL10 showed a lower inflammation score in muscles than those with anti-RVG1 or no treatment. No treatment: no treatment group, anti-CXCL10: anti-CXCL10 treatment group, anti-RVG1: anti-RVG1 treatment group. anti-RVG1, mouse anti-rotavirus IgG1.